Investigation of Protein Biomarkers of Prostate Cancer

This study has been completed.
Sponsor:
Information provided by:
University of New Mexico
ClinicalTrials.gov Identifier:
NCT00323180
First received: May 5, 2006
Last updated: January 6, 2010
Last verified: November 2009
  Purpose

This study is looking at biomarkers in prostate cancer.


Condition
Prostate Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Investigation of Protein Biomarkers of Prostate Cancer

Resource links provided by NLM:


Further study details as provided by University of New Mexico:

Study Start Date: August 2005
Study Completion Date: February 2009
Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)
Detailed Description:
  1. To establish primary culture of epithelial cells isolated from prostatectomy samples
  2. To study biomarkers in prostate cancer
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with prostate cancer

Criteria

Inclusion Criteria:

  • Patients with prostate cancer.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00323180

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
University of New Mexico
Investigators
Principal Investigator: Marco Bisoffi University of New Mexico
  More Information

No publications provided

Responsible Party: Marco Bisoffi; Principal Investigator, Universtiy of New Mexico
ClinicalTrials.gov Identifier: NCT00323180     History of Changes
Other Study ID Numbers: HRRC 03-376
Study First Received: May 5, 2006
Last Updated: January 6, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on October 16, 2014